Quote:

---

I wonder the ‘investigator initiating’ AD study partner will end up being. Or even if it’s a BP, or an MIT.

---

The odds are it's a University with NIH funding. The NIH by now must realize the wrong path that scientists have gone down for decades focusing on tau and amyloid plaques.